PRNewsWire - Health

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
Pharmactive's Saffron Extract Helps Lighten the Mood
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease